Clinical and laboratory profile of patients with sickle cell anemia

Abstract Objective: This study aimed to describe and analyze clinical and laboratory characteristics of patients with sickle cell anemia treated at the Hemominas Foundation, in Divinópolis, Brazil. Furthermore, this study aimed to compare the clinical and laboratory outcomes of the group of patient...

Full description

Bibliographic Details
Main Authors: Phelipe Gabriel dos Santos Sant'Ana, Ariane Moreira Araujo, Cynthia Teixeira Pimenta, Mário Lúcio Pacheco Ker Bezerra, Sílvio Pereira Borges Junior, Viviana Martins Neto, Janaina Sousa Dias, Aline de Freitas Lopes, Danyelle Romana Alves Rios, Melina de Barros Pinheiro
Format: Article
Language:English
Published: Elsevier
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842017000100040&lng=en&tlng=en
_version_ 1818191157524430848
author Phelipe Gabriel dos Santos Sant'Ana
Ariane Moreira Araujo
Cynthia Teixeira Pimenta
Mário Lúcio Pacheco Ker Bezerra
Sílvio Pereira Borges Junior
Viviana Martins Neto
Janaina Sousa Dias
Aline de Freitas Lopes
Danyelle Romana Alves Rios
Melina de Barros Pinheiro
author_facet Phelipe Gabriel dos Santos Sant'Ana
Ariane Moreira Araujo
Cynthia Teixeira Pimenta
Mário Lúcio Pacheco Ker Bezerra
Sílvio Pereira Borges Junior
Viviana Martins Neto
Janaina Sousa Dias
Aline de Freitas Lopes
Danyelle Romana Alves Rios
Melina de Barros Pinheiro
author_sort Phelipe Gabriel dos Santos Sant'Ana
collection DOAJ
description Abstract Objective: This study aimed to describe and analyze clinical and laboratory characteristics of patients with sickle cell anemia treated at the Hemominas Foundation, in Divinópolis, Brazil. Furthermore, this study aimed to compare the clinical and laboratory outcomes of the group of patients treated with hydroxyurea with those patients that were not treated with hydroxyurea. Methods: Clinical and laboratorial data were obtained by analyzing medical records of patients with sickle cell anemia. Results: Data from the medical records of 50 patients were analyzed. Most of the patients were female (56%), aged between 20 and 29 years old. Infections, transfusions, cholecystectomy, splenectomy and systemic arterial hypertension were the most common clinical adverse events of the patients. The most frequent cause of hospitalization was painful crisis. The majority of patients had reduced values of hemoglobin and hematocrit (8.55 ± 1.33 g/dL and 25.7 ± 4.4%, respectively) and increased fetal hemoglobin levels (12 ± 7%). None of the clinical variables was statistically significant on comparing the two groups of patients. Among hematological variables only hemoglobin and hematocrit levels were statistically different between patients treated with hydroxyurea and untreated patients (p-value = 0.005 and p-value = 0.001, respectively). Conclusion: Sickle cell anemia requires treatment and follow-up by a multiprofessional team. A current therapeutic option is hydroxyurea. This drug reduces complications and improves laboratorial parameters of patients. In this study, the use of the drug increased the hemoglobin and hematocrit levels of patients.
first_indexed 2024-12-12T00:10:09Z
format Article
id doaj.art-117d03bd8f554260bef00a3350bad73d
institution Directory Open Access Journal
issn 1806-0870
language English
last_indexed 2024-12-12T00:10:09Z
publisher Elsevier
record_format Article
series Revista Brasileira de Hematologia e Hemoterapia
spelling doaj.art-117d03bd8f554260bef00a3350bad73d2022-12-22T00:44:59ZengElsevierRevista Brasileira de Hematologia e Hemoterapia1806-0870391404510.1016/j.bjhh.2016.09.007S1516-84842017000100040Clinical and laboratory profile of patients with sickle cell anemiaPhelipe Gabriel dos Santos Sant'AnaAriane Moreira AraujoCynthia Teixeira PimentaMário Lúcio Pacheco Ker BezerraSílvio Pereira Borges JuniorViviana Martins NetoJanaina Sousa DiasAline de Freitas LopesDanyelle Romana Alves RiosMelina de Barros PinheiroAbstract Objective: This study aimed to describe and analyze clinical and laboratory characteristics of patients with sickle cell anemia treated at the Hemominas Foundation, in Divinópolis, Brazil. Furthermore, this study aimed to compare the clinical and laboratory outcomes of the group of patients treated with hydroxyurea with those patients that were not treated with hydroxyurea. Methods: Clinical and laboratorial data were obtained by analyzing medical records of patients with sickle cell anemia. Results: Data from the medical records of 50 patients were analyzed. Most of the patients were female (56%), aged between 20 and 29 years old. Infections, transfusions, cholecystectomy, splenectomy and systemic arterial hypertension were the most common clinical adverse events of the patients. The most frequent cause of hospitalization was painful crisis. The majority of patients had reduced values of hemoglobin and hematocrit (8.55 ± 1.33 g/dL and 25.7 ± 4.4%, respectively) and increased fetal hemoglobin levels (12 ± 7%). None of the clinical variables was statistically significant on comparing the two groups of patients. Among hematological variables only hemoglobin and hematocrit levels were statistically different between patients treated with hydroxyurea and untreated patients (p-value = 0.005 and p-value = 0.001, respectively). Conclusion: Sickle cell anemia requires treatment and follow-up by a multiprofessional team. A current therapeutic option is hydroxyurea. This drug reduces complications and improves laboratorial parameters of patients. In this study, the use of the drug increased the hemoglobin and hematocrit levels of patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842017000100040&lng=en&tlng=enSickle cell anemiaHydroxyureaHemoglobin S
spellingShingle Phelipe Gabriel dos Santos Sant'Ana
Ariane Moreira Araujo
Cynthia Teixeira Pimenta
Mário Lúcio Pacheco Ker Bezerra
Sílvio Pereira Borges Junior
Viviana Martins Neto
Janaina Sousa Dias
Aline de Freitas Lopes
Danyelle Romana Alves Rios
Melina de Barros Pinheiro
Clinical and laboratory profile of patients with sickle cell anemia
Revista Brasileira de Hematologia e Hemoterapia
Sickle cell anemia
Hydroxyurea
Hemoglobin S
title Clinical and laboratory profile of patients with sickle cell anemia
title_full Clinical and laboratory profile of patients with sickle cell anemia
title_fullStr Clinical and laboratory profile of patients with sickle cell anemia
title_full_unstemmed Clinical and laboratory profile of patients with sickle cell anemia
title_short Clinical and laboratory profile of patients with sickle cell anemia
title_sort clinical and laboratory profile of patients with sickle cell anemia
topic Sickle cell anemia
Hydroxyurea
Hemoglobin S
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842017000100040&lng=en&tlng=en
work_keys_str_mv AT phelipegabrieldossantossantana clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT arianemoreiraaraujo clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT cynthiateixeirapimenta clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT marioluciopachecokerbezerra clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT silviopereiraborgesjunior clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT vivianamartinsneto clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT janainasousadias clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT alinedefreitaslopes clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT danyelleromanaalvesrios clinicalandlaboratoryprofileofpatientswithsicklecellanemia
AT melinadebarrospinheiro clinicalandlaboratoryprofileofpatientswithsicklecellanemia